source clustersSource Clusters is the single source of information on regional development in the life sciences sector worldwide.

With content providing broad overviews as well as in-depth coverage of business development trends, company activities, life science cluster collaborations, multi-partner scientific projects and its extensive news coverage, Source Clusters presents the latest management, research, technology and regional development information serving the needs of executives in the internationally growing life sciences sector.

Source Clusters is the essential resource for companies, incubators, science parks, clusters and regional development agencies looking to find a new location or attract new business and exploit new opportunities across the life sciences sector.

Evonetix appoints Stephanie Brooking as Head of Product Management

Evonetix Stephanie Brooking 19.1.19Cambridge, UK-based EVONETIX LTD, a company pioneering an innovative approach to scalable and high-fidelity gene synthesis, has appointed Stephanie Brooking as Head of Product Management. Evonetix aims to utilise its innovative silicon chip approach to deliver a high-throughput solution for the synthesis and assembly of DNA molecules with high fidelity and Brooking will help to define the company’s strategy for market entry and longer-term product marketing for its novel gene synthesis products.

Brooking has more than 20 years’ commercial experience in the life science industry, having worked in operational, sales and marketing leadership roles to support product development and introduction, commercial launch planning and marketing content strategy and has helped execute programmes to open new geographies and market opportunities within the research, clinical, agricultural, pharmaceutical and biotechnology sectors. Her previous positions include VP of Marketing and Sales at Cambridge Epigenetix and Global Commercial Director at Oxford Nanopore Technologies, and she has also held senior positions at Illumina, Applied Biosystems, Affymetrix and GE Healthcare (Amersham Pharmacia Biotech). She first began her career working on the Human Genome Project at the Wellcome Trust Sanger Institute.

For further information about Evonetix and its products visit

Last modified onSunday, 27 January 2019 08:49

Related items

Latest from Tom Mulligan